key: cord-0726392-yne0dus9 authors: Debnath, Monojit; Berk, Michael; Maes, Michael title: Changing dynamics of psychoneuroimmunology during COVID-19 pandemic date: 2020-06-15 journal: Brain Behav Immun Health DOI: 10.1016/j.bbih.2020.100096 sha: ef58764db60a9a61a6e176ccd04c8344f8300646 doc_id: 726392 cord_uid: yne0dus9 The Coronavirus Disease-2019 (COVID-19) pandemic has led to a global health care crisis in recent times. Emerging research suggest an unanticipated impact of COVID-19 on mental and/or psychological health of both the general community and affected individuals. The fear of the COVID-19 epidemic and the consequent lockdown and economic crisis has led to globally increased psychological distress. The biological bases of immediate and new onset of psychiatric symptoms in individuals with COVID-19 are not yet known. COVID-19 infection may lead to activated immune-inflammatory pathways and cytokine storm. Activated immune-inflammatory pathways, especially chronic low-grade inflammation, are associated with major psychiatric disorders in at least a subset of individuals. We propose that both the (sub)chronic inflammatory response and cytokine storm might crucially be involved in the immediate manifestation of neuropsychiatric symptoms in individuals with COVID-19 infection as well as heightened expression of psychiatric symptoms in COVID-19 infected individuals with prior psychiatric conditions. These events might expand concepts in psychoneuroimmunology, with the importance of chronic-low grade inflammation augmented by the cytokine storm hypothesis. Additionally, this might augment and refine diagnosis and prognostic management as well as treatment. There is a growing recognition that Coronavirus disease 2019 , caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) possesses neurotropic properties and can lead to neurological manifestations similar to SARS and Middle East Respiratory Syndrome (MERS). COVID-19 is envisaged to have enduring cognitive, psychological and psychiatric consequences, however, data pertaining to this are albeit limited. There is a growing anticipation that COVID-19 might cause delirium, depression, anxiety, fatigue, and post-traumatic stress disorder (PTSD) (Rogers et al., 2020) . A recent report suggests immediate psychological distress, especially higher levels of depression, anxiety and PTSD symptoms in quarantined patients with COVID-19 (Guo et al., 2020) . As observed in SARS survivors, COVID-19 survivors may also have long-term psychiatric morbidities (Mak et al., 2009 ). Various mechanisms are being proposed to contribute to the neurobiological sequelae of COVID-19. SARS-CoV-2 can transmigrate to brain by disrupting blood brain barrier (BBB) and interact with the angiotensin-converting enzyme 2 (ACE2) receptor, expressed by brain tissue. The ACE2 receptor has pleotropic roles in the stress response system and mood regulation (Vian et al., 2017) . SARS-CoV-2 could affect the brain and behavior of people by causing i) direct neuronal damage, ii) immune injury, and iii) hypoxia and biogenesis. Contextually, these mechanisms have consistently been implicated in the pathogenetic pathways of many psychiatric disorders. However, one pertinent question arises "how COVID-19 associated immune changes will influence the risk, progression and outcomes of psychiatric conditions?" The genesis of a cytokine storm is evident in both infectious and non-infections disease states occurring throughout the body, including brain. It was used to describe the underlying mechanisms of multiple infectious diseases such as variola virus, severe influenza (H1N1, H5N1), and SARS. The CNS is particularly vulnerable to cytokine storms as most of the cytokines involved in cytokine storm are either produced within the brain or reach brain from periphery, especially in the context of disrupted BBB permeability . Notably, the cytokine storm appears to drive chronic neurotoxic and neurodegenerative processes in conditions like post-traumatic brain injury, post-stroke and Alzheimer's disease. Multiple sclerosis, a classical example neuroinflammatory disorder of the CNS is suggested to be associated with cytokine storm (Link, 1998) . The acute spike in circulating inflammatory moieties has also been associated with post-operative cognitive decline (Skvarc et al., 2018) . Evidence of the CNS impact of a cytokine storm in infectious diseases are relatively sparse. Acute necrotizing encephalopathy (ANE) is the most severe type of influenza-associated encephalopathy and a rare complication of influenza; this has been associated with intracranial cytokine storms. There is a significant lack of information whether cytokine storm leads to neuroinflammation in individuals with COVID-19 infection. Interestingly, a study based on CT and MRI features for the first time reports the presence of COVID-19 associated acute necrotizing encephalopathy, indicating a potential consequence of a CNS cytokine storm in patients with COVID-19 infection (Poyiadji et al., 2020) . Immunopathogenesis is one of the predominant etiological models of major psychiatric disorders. Activation of immune-inflammatory pathways, both peripherally and in the brain has been linked with the genesis and progression of neuropsychiatric disorders. It is noteworthy that most of the neuropsychiatric conditions have consistently been linked to chronic low-grade inflammation. This implies a sustained low-level inflammation throughout the body. Systemic inflammation causing neuroinflammation is a well-documented fact. The notion that cytokine storm can lead to neuropsychiatric disorders has not been comprehensively tested so far. Most of the cytokines involved in a cytokine storm are associated with neuropsychiatric disorders like schizophrenia, and bipolar disorder. Indirect evidence indicates that a cytokine storm could be involved in driving the manifestation of psychiatric symptoms. Influenza infections have been shown to result into cytokine storm. Besides this, SARS and MERS also lead to cytokine storm. Contextually, influenza infections, SARS and MERS are shown to be associated with neuropsychiatric symptoms. Based on this understanding, a neurobiological consequences of cytokine storm seems highly likely in neuropsychiatric conditions. There is a concern whether patients with psychiatric conditions will experience more psychiatric symptoms during COVID-19 pandemic. A recent study reports that COVID-19 has severe negative psychological impact in patients with pre-existing psychiatric conditions and these patients displayed higher risk of developing symptoms of PTSD, depression, anxiety, stress and insomnia (Hao et al., 2020) . These patients with SARS-CoV-2 infection mostly exhibit a cytokine storm. Does this mean that patients with pre-existing psychiatric disorders experience a higher risk of psychiatric episodes due to dramatic increase of inflammatory response elicited by cytokine storm? Through there is a significant lack of data towards this notion, this seems to be a possibility. Support towards this derives from studies showing coronavirus immunoreactivity based on the measures of antibody levels and seroprevalence of certain coronavirus strains in patients with recent onset psychotic symptoms (Severance et al., 2011) . A study examining correlation between psychological distress and peripheral inflammation demonstrated positive correlation between the levels of depression and levels of C-reactive protein (CRP) among patients COVID-19 quarantined patients with depression symptoms (Guo et al., 2020) . SARS-CoV-2 triggering new neuropsychiatric conditions were shown to be accompanied by elevated CRP levels. We propose that SARS-CoV-2 associated immediate or new-onset neuropsychiatric manifestations are likely immune-mediated. The presence of a cytokine storm involved in the severity and mortality of COVID-19 appears to escalate psychiatric manifestations. This also seems to exert deleterious effects on multiple organs and systems and lead to longlasting changes in brain and behaviour. The long-standing theory that chronic low-grade inflammation lead to psychiatric diseases may not constitute the full picture of the underlying pathway of immediate psychological distress. It is therefore assumed that the classical concept of chronic low-grade inflammation in psychosis may require a revision and may well be augmented by the cytokine storm model. Most people suffering from COVID-19 recover without experiencing severe neuropsychiatric conditions, with short-term delirium as the most common neuropsychiatric symptom. People with pre-existing neuropsychiatric conditions might have a reduced incidence of SARS-CoV-2 or might be protected from COVID-19. This could be explained in the light of chronic-low Immediate psychological distress in quarantined patients with COVID-19 and its association with peripheral inflammation: a mixed-method study Do psychiatric patients experience more psychiatric symptoms during COVID-19 pandemic and lockdown? A case-control study with service and research implications for immunopsychiatry The cytokine storm in multiple sclerosis The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder Long-term psychiatric morbidities among SARS survivors Leaky brain in neurological and psychiatric disorders: Drivers and consequences. The Australian and New Zealand journal of psychiatry Activation of the immuneinflammatory response system and the compensatory immune-regulatory system in antipsychotic naive first episode psychosis Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. The lancet Coronavirus immunoreactivity in individuals with a recent onset of psychotic symptoms Post-Operative Cognitive Dysfunction: An exploration of the inflammatory hypothesis and novel therapies The renin-angiotensin system: a possible new target for depression